Authors



Nancy Baum, PhD

Latest:

Tracking Spending Among Commercially Insured Beneficiaries Using a Distributed Data Model

The authors demonstrate the utility of distributed data models for reporting of local trends and variation in utilization, pricing, and spending for commercially insured beneficiaries.





Amy Wei, PharmD

Latest:

Clinical Consequences of Disseminating the Rosiglitazone FDA Safety Warning

Notifying patients and providers about the rosiglitazone cardiovascular safety alert led to sweeping changes in drug therapy that were initiated by both physicians and patients.


Elyse N. Reamer, BS

Latest:

Primary Care Appointment Availability and Nonphysician Providers One Year After Medicaid Expansion

After Medicaid expansion in Michigan, appointment availability for new Medicaid patients stably increased-this is perhaps attributable to increasing proportions of appointments scheduled with nonphysician providers.


Ya-chen Tina Shih, PhD

Latest:

Infused Chemotherapy Use in the Elderly After Patent Expiration

As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.


Lisa Marie Yarnell, PhD

Latest:

Diabetes and Employment Productivity: Does Diabetes Management Matter?

Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.


Tanya Temkin, MPH

Latest:

Optimizing the Use of Telephone Nursing Advice for Upper Respiratory Infection Symptoms

Telephone nursing advice for home care offers an effective and clinically appropriate way to manage upper respiratory infection symptoms for adult members of a large integrated health plan.



Simon S. K. Tang, MPH

Latest:

Effect of Patient Comorbidities on Filling of Antihypertensive Prescriptions

Patients in a Medicaid managed care plan who had cardiovascular comorbidities were not more likely to fill antihypertensive prescriptions than patients without these conditions.


Alex J. Brown, MEng, MBA

Latest:

The Value of Decreasing Health Cost Volatility

Even if they leave average cost the same, interventions that decrease cost variability have economic value.





Stephen Stemkowski, PhD, MHA

Latest:

Claims Identification of Patients With Severe Cancer-Related Symptoms

The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.



Joel S. Weissman, PhD

Latest:

Geographic Variation in Medicare and the Military Healthcare System

Geographic variation in healthcare spending and utilization within the Military Health System is higher and significantly correlated with Medicare across hospital referral regions.




managed care, healthcare, cancer, melanoma, hospice, ipilimumab, vemurafenib, metastatic, survival rates, end-of-life, healthcare costs, Affordable Care Act, patient-centered, palliative care

Latest:

More Hospice Care Meant Longer Survival, Lower End-of-Life Costs for Metastatic Melanoma Patients

A study in The American Journal of Managed Care found that longer stays in hospice were associated with longer survival and lower end-of-life costs for patients with metastatic melanoma, a particularly deadly and increasingly common form of cancer.





John Trombley II, MPP

Latest:

Emergency Department Use: A Reflection of Poor Primary Care Access?

An original emergency department patient survey, insurance claims data, and administrative records are used to examine the characteristics of nonurgent users.


Jeffrey A. Linder, MD, MPH

Latest:

Antibiotic Prescribing for Respiratory Infections at Retail Clinics, Physician Practices, and Emergency Departments

There are concerns that retail clinics provide inferior quality of care. The authors found no difference in quality among retail clinics, physician offices, and emergency departments.



Richard Zeckhauser, PhD

Latest:

Medicare Advantage: What Explains Its Robust Health?

Payment policy, health plan characteristics, and Medicare beneficiary characteristics come together to foster continued growth in the Medicare Advantage program.


Stephen Stemkowski, PhD

Latest:

Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD

Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo